800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
Sponsored| Name | Address | City |
|---|---|---|
| Spokane Comprehensive Treatment Center | 4305 E Trent Ave | Spokane |
| Spokane Regional Health District Treatment Services | 1101 West College Ave. | Spokane |
| CHAS Valley Medical Clinic | 15812 E. Indiana Ave | Spokane |
| WCHS, Inc. | 15812 E. Indiana Ave | Spokane Valley |
No results found!
Finding Opioid Use Disorder Treatment in Spokane
Spokane is the medical hub of eastern Washington, and that means people here can usually reach more than one kind of medication treatment for opioid use disorder (OUD) without leaving the county.
Some clinics are federally certified opioid treatment programs (OTPs) that dispense methadone on site. Others are office-based practices where a clinician prescribes buprenorphine or naltrexone that you fill at a pharmacy. The listings on this page cover Spokane and the surrounding Inland Northwest, and they represent the three medications approved for OUD: methadone, buprenorphine (including Suboxone) and naltrexone.
If you are deciding where to begin, you can call a program directly or use the helpline on this page to talk through the options.
Your Treatment Options and Where to Get Them
There are three medications approved for opioid use disorder, and they are not dispensed the same way. Knowing the difference tells you what each clinic on this page can actually offer.
Methadone is a full opioid agonist that eases withdrawal and cravings. For OUD, it is available only through a certified opioid treatment program, not a regular pharmacy, so you receive it at the clinic, especially early in treatment.
Buprenorphine, including Suboxone and other buprenorphine-naloxone products, is a partial agonist with a ceiling effect that lowers overdose risk. Since 2023, any clinician with a standard DEA registration can prescribe it, so you can get it in a doctor’s office and fill it at a pharmacy or through a clinic. It also comes as a monthly extended-release injection (Sublocade).
Naltrexone, including the monthly Vivitrol injection, is not an opioid at all; it blocks opioid effects, and treatment starts only after you have been off opioids for a set time. Any licensed prescriber can order it.
Those medications are delivered in two settings: an opioid treatment program (OTP), which handles methadone and often buprenorphine, and office-based opioid treatment (OBOT), where a prescriber manages buprenorphine or naltrexone.
If you want to understand the trade-offs before you call, it helps to read how methadone and Suboxone compare and what to expect from a methadone clinic.
Starting Treatment, and What the First Visit Looks Like
The first step is usually an intake assessment where a clinician reviews your history, confirms a diagnosis and works with you to determine which medication best fits your needs. Bring a photo ID and insurance information if you have them, though many programs will begin the conversation without them.
If you use fentanyl, timing matters for buprenorphine. Starting it too soon after fentanyl can trigger sudden, severe withdrawal, called precipitated withdrawal, so a clinician plans the first dose with you and may suggest an alternative approach. This is a medical detail to talk through, not a reason to wait. Some Spokane programs offer same-day or next-day starts, so be sure to ask when you call.
You can also read more about methadone treatment when fentanyl is involved.
Take-home Doses, Telehealth and the Rules as They Stand Now
Federal rules changed in ways that matter if you are transferring in or restarting. For example, SAMHSA’s 2024 update to the OTP standards expanded take-home methadone. This allowed up to a 28-day supply for patients who are stable in treatment, with eligibility decided by the program.
The same update allowed treatment to start by telehealth and removed the old requirement that a person show a one-year history of opioid addiction before being admitted. Methadone for OUD is still dispensed through an OTP
For buprenorphine, telehealth is broader. As of 2026, it can be started remotely, including by phone in many cases, without a prior in-person visit. Those telehealth rules run through the end of 2026 and are still being finalized, so confirm what is current with the provider.
If you are moving your care, ask a program about guest dosing and how it handles transfers, and read why staying consistent with your methadone dose matters during a transition.
Paying for treatment in Spokane
Wondering how to pay for treatment can cause added stress during an already stressful time. Thankfully, there are several avenues to help you cover the cost of care.
Washington’s Medicaid program, Apple Health, covers all three opioid use disorder medications, and most enrollees receive care through an Integrated Managed Care plan. Additionally, Behavioral Health Services Only plan is available for some who are not in full managed care. Some buprenorphine products require prior authorization through Apple Health, which the clinic typically handles.
If you have private insurance or Medicare, OUD medications are generally covered, though the details vary by plan. If you are uninsured, many programs offer self-pay or sliding-scale fees and can help you apply for coverage, and federal block grant funding supports treatment for people who cannot pay.
Be sure to ask each program what it accepts when you call.
Fentanyl and Overdose in Spokane County
The local picture is serious, and it is also the reason treatment access here has grown. The Spokane County Medical Examiner confirmed 353 overdose deaths in 2024, up about 17 percent from 301 in 2023, with fentanyl present in roughly 78 percent of the 2024 deaths. The deaths have been concentrated in central Spokane, including the 99201 ZIP code, West Central, and the downtown core.
There is a more hopeful recent signal with the Spokane Regional Health District reporting that EMS responses to suspected opioid overdoses in 2026 were running about 30 percent below 2025. Medication treatment is the single most effective response to this kind of fentanyl risk, and the programs on this page are part of that response.
If you want the wider context, see this overview of opioid addiction and how it is treated.
Pregnancy, Reentry and Other Situations That Need a Specific Plan
Some situations call for a tailored path.
If you are pregnant, medication treatment with methadone or buprenorphine is the recommended standard of care, because untreated OUD carries greater risk to you and the baby than treatment does. In addition to MOUD, a clinician also plans for neonatal opioid withdrawal syndrome (NOWS) so the newborn can be monitored and cared for along with the birthing individual.
Spokane is home to Maddie’s Place, a nonprofit recovery nursery that cares for infants exposed to substances before birth and supports their families, which is a resource few communities have. Seeking treatment while pregnant is a protective step, and Washington encourages care through a Plan of Safe Care rather than punishment.
For people leaving jail or entering treatment through a court or probation, ask programs about assessment timelines and any documentation you need.
Families supporting someone can start with this guide for loved ones helping someone into treatment, and anyone weighing options during pregnancy can read more about methadone and pregnancy.
Naloxone and Staying Safe
Naloxone reverses an opioid overdose, and in Washington you do not need an individual prescription to get it. In fact, a statewide standing order lets any resident pick it up directly from a pharmacy. In addition, the Spokane Regional Health District distributes naloxone and offers overdose education through its syringe services program. If you or someone you love is in treatment, carrying naloxone is a sensible backup, as a return to use is a common, manageable part of recovery rather than a failure.
Washington’s 911 Good Samaritan Overdose Law protects both the person who calls for help and the person overdosing from drug-possession charges, so calling 911 is always the right move. Learn the signs and response steps for an opioid overdose.
Questions People in Spokane Ask
Is methadone or Suboxone the better choice?
Neither is better in general. The right choice is based on each individual’s needs, including your history, your schedule and your goals. Methadone is a strong option for many with heavy fentanyl use and is dispensed at an OTP. Buprenorphine (Suboxone) has a ceiling effect that lowers overdose risk and can be prescribed in an office and filled at a pharmacy.
Can I start Suboxone by telehealth in Spokane?
Often, yes. As of 2026, buprenorphine can be started through telehealth, including by phone in many cases, without a prior in-person visit. These rules run through the end of 2026 and are still being finalized, so confirm current options with the provider you choose.
Do I have to go to the clinic every day for methadone?
Early in treatment, dosing is usually daily and observed at the OTP. As you become stable, federal rules now allow take-home methadone, up to a 28-day supply, with the program deciding eligibility based on your progress.
What does treatment cost if I have no insurance?
Many Spokane programs offer sliding-scale or self-pay options and can help you enroll in Apple Health. Federal block grant funds also support treatment for people who cannot pay. Ask each program directly about cost when you call.
Is methadone just trading one addiction for another?
No. Taking a prescribed medication that stabilizes your brain chemistry, under medical supervision, is treatment for a chronic condition, not a new addiction. You can read more about whether methadone is habit-forming and how that differs from continued OUD.
Last reviewed and disclosures
Last reviewed July 2026.
Sources: Spokane County Medical Examiner overdose data, 2024 and 2025 (reported via local coverage, 2025 and 2026); Spokane Regional Health District, opioid and overdose response, 2026; Washington State Health Care Authority, Apple Health coverage of substance use disorder treatment; Washington State Department of Health statewide naloxone standing order (RCW 69.41.095) and 911 Good Samaritan Overdose Law (RCW 69.50.315); SAMHSA and DEA, 2024 OTP standards (42 CFR Part 8) and 2025 to 2026 buprenorphine telemedicine rules; FDA and SAMHSA, medications for opioid use disorder.
Methadone Centers is an informational directory, not a treatment provider, and does not offer medical advice. Content is for education and does not replace care from a qualified clinician.
The helpline on this site is a sponsored resource. Calls may be answered by a paid advertiser among the treatment providers in our network.
Last Updated: August 1, 2026